Showing results (21-30 of 258) with videos related to
Sort By:
Pageof 26
Expert Opinion on Therapeutic Targets|December 4, 2003
11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative diseaseBrian R Walker, Jonathan R SecklTrends in Endocrinology and Metabolism: TEM|November 3, 2004
11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memoryJonathan R Seckl, Brian R WalkerAnnals of the New York Academy of Sciences|January 29, 2005
Glucocorticoid programmingJonathan R Seckl, Michael J MeaneyAnnals of the New York Academy of Sciences|August 8, 2006
Glucocorticoid "programming" and PTSD riskJonathan R Seckl, Michael J MeaneyNature Clinical Practice. Endocrinology & Metabolism|May 23, 2007
Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiologyJonathan R Seckl, Megan C HolmesNeurochemical Research|October 27, 2007
11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)functionKaren E Chapman, Jonathan R SecklFrontiers in Behavioral Neuroscience|October 15, 2009
Prenatal stress, glucocorticoids and the programming of adult diseaseElizabeth C Cottrell, Jonathan R SecklCell Metabolism|April 9, 2008
Diabetes and cognitive decline: are steroids the missing link?Alasdair M J MacLullich, Jonathan R SecklFrontiers in Aging Neuroscience|September 7, 2012
Local amplification of glucocorticoids in the aging brain and impaired spatial memoryJoyce L W Yau, Jonathan R SecklDiabetes|March 30, 2004
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient miceNicholas M Morton, Janice M Paterson, Hiroaki Masuzaki, et al.Pageof 26